Efficacy and safety of micafungin for the treatment of patients with proven or probable invasive aspergillosis: A non-comparative, multicenter, phase IV, open-label study

INTRODUCTION: Few studies have assessed the efficacy and safety of micafungin in patients with proven or probable invasive aspergillosis (IA). This was the aim of the current study, which was conducted in 22 hospitals in China, where micafungin was approved for treatment of IA in 2006. METHODS: This...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Yu, Song, Yongping, Zhou, Fang, Liu, Ting, Jiang, Ming, Zhao, Xielan, Huang, Xiaojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392632/
https://www.ncbi.nlm.nih.gov/pubmed/29384927
http://dx.doi.org/10.1097/MD.0000000000009443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392632/
https://www.ncbi.nlm.nih.gov/pubmed/29384927
http://dx.doi.org/10.1097/MD.0000000000009443

Ejemplares similares